XML 21 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2023
Jan. 31, 2024
Jun. 30, 2023
Entity Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-35565    
Entry Registrant Name AbbVie Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 32-0375147    
Entity Address, Address Line One 1 North Waukegan Road    
Entity Address, City or Town North Chicago    
Entity Address, State or Province IL    
Entity Address, Postal Zip Code 60064-6400    
City Area Code 847    
Local Phone Number 932-7900    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 235,629,692,915
Entity Common Stock, Shares Outstanding   1,766,473,359  
Documents Incorporated by Reference Portions of the 2024 AbbVie Inc. Proxy Statement are incorporated by reference into Part III. The Definitive Proxy Statement will be filed on or about March 18, 2024.    
Entity Central Index Key 0001551152    
Amendment Flag false    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Common stock | NEW YORK STOCK EXCHANGE, INC.      
Entity Information [Line Items]      
Title of 12(b) Security Common Stock, par value $0.01 per share    
Trading Symbol ABBV    
Security Exchange Name NYSE    
Common stock | CHICAGO STOCK EXCHANGE, INC      
Entity Information [Line Items]      
Title of 12(b) Security Common Stock, par value $0.01 per share    
Trading Symbol ABBV    
Security Exchange Name CHX    
Sec 1.375 Senior Notes Due 2024 | NEW YORK STOCK EXCHANGE, INC.      
Entity Information [Line Items]      
Title of 12(b) Security 1.375% Senior Notes due 2024    
Trading Symbol ABBV24    
Security Exchange Name NYSE    
Sec 1.250 Senior Notes Due 2024 | NEW YORK STOCK EXCHANGE, INC.      
Entity Information [Line Items]      
Title of 12(b) Security 1.250% Senior Notes due 2024    
Trading Symbol ABBV24B    
Security Exchange Name NYSE    
Sec 0.750 Senior Notes Due 2027 | NEW YORK STOCK EXCHANGE, INC.      
Entity Information [Line Items]      
Title of 12(b) Security 0.750% Senior Notes due 2027    
Trading Symbol ABBV27    
Security Exchange Name NYSE    
Sec 2.125 Senior Notes due 2028 | NEW YORK STOCK EXCHANGE, INC.      
Entity Information [Line Items]      
Title of 12(b) Security 2.125% Senior Notes due 2028    
Trading Symbol ABBV28    
Security Exchange Name NYSE    
Sec 2.625 Senior Notes Due 2028 | NEW YORK STOCK EXCHANGE, INC.      
Entity Information [Line Items]      
Title of 12(b) Security 2.625% Senior Notes due 2028    
Trading Symbol ABBV28B    
Security Exchange Name NYSE    
Sec 2.125 Senior Notes Due 2029 | NEW YORK STOCK EXCHANGE, INC.      
Entity Information [Line Items]      
Title of 12(b) Security 2.125% Senior Notes due 2029    
Trading Symbol ABBV29    
Security Exchange Name NYSE    
Sec 1.250 Senior Notes Due 2031 | NEW YORK STOCK EXCHANGE, INC.      
Entity Information [Line Items]      
Title of 12(b) Security 1.250% Senior Notes due 2031    
Trading Symbol ABBV31    
Security Exchange Name NYSE